| Dr E Michael Canham, MD | |
|
1400 Jackson St, Denver, CO 80206-2761 | |
| (303) 388-4461 | |
| (303) 270-2174 |
| Full Name | Dr E Michael Canham |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 1400 Jackson St, Denver, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770690620 | NPI | - | NPPES |
| 01211838 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 21180 (Colorado) | Primary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | 21183 (Colorado) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr E Michael Canham, MD 1400 Jackson St, Denver, CO 80206-2761 Ph: (303) 388-4461 | Dr E Michael Canham, MD 1400 Jackson St, Denver, CO 80206-2761 Ph: (303) 388-4461 |
News Archive
Cardiovascular disease, including heart disease and stroke, is the leading cause of death in the United States. To help combat this epidemic, studies throughout the United States pinpoint dietary guidelines to reduce risk including a recent release from the American Heart Association which stated that hypertensive patients should avoid alcoholic beverages.
One of the most common causes of diarrhea worldwide – accounting for millions of cases and tens of thousands of deaths, mostly of small children – is the parasiteCryptosporidium.
The Life Sciences Discovery Fund (LSDF) today announced $1.1 million in five Proof of Concept grants to Washington for-profit and non-profit organizations to foster the translation of health-related products from the laboratory into the commercial marketplace.
Pall Corporation's GeneDisc System is helping German authorities screen for a deadly strain of E.coli that has sickened nearly 3000 people and disrupted that nation's food industry. Pall's GeneDisc technology is being used by Germany's national reference laboratory to expedite testing of food samples for the toxic strain of the pathogen known as E.coli O104:H4.
ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today introduced an advanced respiratory clinical trial solution to centrally capture, measure and analyze Lung Clearance Index data, in near real-time, to assess lung performance with more precision than traditional spirometry measures.
› Verified 3 days ago
Katrina Wagoner-hursh, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1835 Franklin St, Denver, CO 80218 Phone: 303-338-4545 | |
Emily Martin Jones, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 8111 E Lowry Blvd, Denver, CO 80230 Phone: 720-848-0000 | |
Dr. Jesus Heliodoro Hermosillo Rodriguez, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2045 N Franklin St, Denver, CO 80205 Phone: 303-338-4545 | |
Margaret Hay, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1601 E 19th Ave Ste 3100, Denver, CO 80218 Phone: 303-863-0300 Fax: 303-863-7014 | |
Dr. Alan W Burgess, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1601 E 19th Ave Ste 6000, Denver, CO 80218 Phone: 303-861-7001 Fax: 303-861-8624 | |
Dr. Sahibzada Mohsin Shah, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 777 Bannock St, Denver, CO 80204 Phone: 303-436-6000 | |
Shyam M Parkhie, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 130 Rampart Way, 300b, Denver, CO 80230 Phone: 720-343-1562 Fax: 720-343-1563 |